Vendor-to-vendor education to improve malaria treatment by private drug outlets in Bungoma District, Kenya

Malaria Journal

Table 5 Drugs sold to mystery shoppers, by programme status and type of outlet (in %)

Drugs sold	Informed outlets	Control outlets	All outlets	Signif.*
*Shop/Kiosk*	( *n = 136* )	( *n = 238* )	( *n = 374* )	.000
SP	31.6	2.5	13.1
AQ	28.7	33.2	31.6
CQ	5.1	18.9	13.9
Other anti-malarial	0.0	0.4	0.3
Not an anti-malarial	5.9	6.7	6.4
Not sold any drug	28.7	38.2	34.8
*Pharmacy/Chemist*	( *n = 54* )	( *n = 38* )	( *n = 92* )	.352
SP	24.1	23.7	23.9
AQ	48.1	63.2	54.3
CQ	20.4	10.5	16.3
Other anti-malarial	0.0	0.0	0.0
Not an anti-malarial	5.6	0.0	3.3
Not sold any drug	1.9	2.6	2.2
*Private Clinic*	( *n = 12* )	( *n = 26* )	( *n = 38* )	.369
SP	16.7	3.8	7.9
AQ	33.3	30.8	31.6
CQ	8.3	26.9	21.1
Other anti-malarial	0.0	7.7	5.3
Not an anti-malarial	0.0	0.0	0.0
Not sold any drug	41.7	30.8	34.2
*Total*	(n = 202)	(n = 302)	(n = 504)	.000
SP	28.7	5.3	14.7
AQ	34.2	36.8	35.7
CQ	9.4	18.5	14.9
Other anti-malarial	0.0	1.0	0.6
Not an anti-malarial	5.4	5.3	5.3
Not sold any drug	22.3	33.1	28.8

Notes: SP = sulfadoxine-pyrimethamine (recommended first-line drug); Amodiaquine (second-line drug only); Chloroquine (not recommended, to be sold by prescription only); Other anti-malarial (quinine, etc.); Not an anti-malarial (anti-pyretics or anti-biotics only). *Based on Pearson chi-square.

ISSN: 1475-2875